Research & Literature

Outcome of pulmonary rehabilitation in patients after acute exacerbation of chronic obstructive pulmonary disease.

Deepak TH, Mohapatra PR, Janmeja AK, et al.

The Indian journal of chest diseases & allied sciences 2014; (56(1)):7-12.

Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort.

van Dijk W, Tan W, Li P, et al.

Annals of family medicine 2015; (13(1)):41-8 doi:10.1370/afm.1714.

Comparative Effectiveness of Noninvasive and Invasive Ventilation in Critically Ill Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Stefan MS, Nathanson BH, Higgins TL, et al.

Critical care medicine 2015; (43(7)):1386-94 doi:10.1097/CCM.0000000000000945.

Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial.

Davey C, Zoumot Z, Jordan S, et al.

Lancet (London, England) 2015; (386(9998)):1066-73.

Outpatient Chronic Obstructive Pulmonary Disease Management: Going for the GOLD.

Bellinger CR, Peters SP

The journal of allergy and clinical immunology. In practice 2015; (3(4)):471-8; quiz 479-80.

Association of Psychological Disorders With 30-Day Readmission Rates in Patients With COPD.

Singh G, Zhang W, Kuo YF, Sharma G

Chest 2016; (149(4)):905-15.

Surgical Approaches to Treating Emphysema: Lung Volume Reduction Surgery, Bullectomy, and Lung Transplantation.

Marchetti N, Criner GJ

Seminars in respiratory and critical care medicine 2015; (36(4)):592-608 doi:10.1055/s-0035-1556064.

New episodes of depression among Medicare beneficiaries with chronic obstructive pulmonary disease.

Albrecht JS, Huang TY, Park Y, et al.

International journal of geriatric psychiatry 2016; (31(5)):441-9 doi:10.1002/gps.4348.

Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis.

Greulich T, Vogelmeier CF

Therapeutic advances in respiratory disease 2016; (10(1)):72-84 doi:10.1177/1753465815602162.

Evaluation of Patients With Suspected Acute Pulmonary Embolism: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians.

Raja AS, Greenberg JO, Qaseem A, et al.

Annals of internal medicine 2015; (163(9)):701-11 doi:10.7326/M14-1772.

Features of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional study.

Huang WC, Wu MF, Chen HC, et al.

NPJ primary care respiratory medicine 2015; (25()):15063 doi:10.1038/npjpcrm.2015.63.

Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity.

Harvey BG, Strulovici-Barel Y, Kaner RJ, et al.

The European respiratory journal 2015; (46(6)):1589-1597 doi:10.1183/13993003.02377-2014.

Pulmonary Artery Abnormalities in Ex-smokers with and without Airflow Obstruction.

Lindenmaier TJ, Kirby M, Paulin G, et al.

COPD 2016; (13(2)):224-34 doi:10.3109/15412555.2015.1074666.

Fat-Free Mass Index for Evaluating the Nutritional Status and Disease Severity in COPD.

Luo Y, Zhou L, Li Y, et al.

Respiratory care 2016; (61(5)):680-8 doi:10.4187/respcare.04358.

Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis and Other Diseases of Mucus Clearance.

Raju SV, Solomon GM, Dransfield MT, Rowe SM

Clinics in chest medicine 2016; (37(1)):147-58.

Exacerbations of COPD.

Pavord ID, Jones PW, Burgel PR, Rabe KF

International journal of chronic obstructive pulmonary disease 2016; (11 Spec Iss()):21-30 doi:10.2147/COPD.S85978.

Mucus Hyperconcentration as a Unifying Aspect of the Chronic Bronchitic Phenotype.

Button B, Anderson WH, Boucher RC

Annals of the American Thoracic Society 2016; (13 Suppl 2()):S156-62 doi:10.1513/AnnalsATS.201507-455KV.

Chronic obstructive pulmonary disease.

Barnes PJ, Burney PG, Silverman EK, et al.

Nature reviews. Disease primers 2015; (1()):15076 doi:10.1038/nrdp.2015.76.

Prevalence and Localization of Pulmonary Embolism in Unexplained Acute Exacerbations of COPD: A Systematic Review and Meta-analysis.

Aleva FE, Voets LWLM, Simons SO, et al.

Chest 2017; (151(3)):544-554 doi:10.1016/j.chest.2016.07.034.

Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.

Dransfield MT, Kunisaki KM, Strand MJ, et al.

American journal of respiratory and critical care medicine 2017; (195(3)):324-330 doi:10.1164/rccm.201605-1014OC.

Office-based DLCO tests help pulmonologists to make important clinical decisions.

Enright Md P

Respiratory investigation 2016; (54(5)):305-11.

The Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor Augments Mucociliary Clearance Abrogating Cystic Fibrosis Transmembrane Conductance Regulator Inhibition by Cigarette Smoke.

Raju SV, Lin VY, Liu L, et al.

American journal of respiratory cell and molecular biology 2017; (56(1)):99-108 doi:10.1165/rcmb.2016-0226OC.

Lung volume reduction surgery for diffuse emphysema.

van Agteren JE, Carson KV, Tiong LU, Smith BJ

The Cochrane database of systematic reviews 2016; (10()):CD001001 doi:10.1002/14651858.CD001001.pub3.

A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation.

, Albert RK, Au DH, et al.

The New England journal of medicine 2016; (375(17)):1617-1627 doi:10.1056/NEJMoa1604344.

Multi-center, randomized, placebo-controlled trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease: a study protocol for the INOX trial.

Lacasse Y, Bernard S, Sériès F, et al.

BMC pulmonary medicine 2017; (17(1)):8 doi:10.1186/s12890-016-0343-9.

Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.

Walters JA, Tang JN, Poole P, Wood-Baker R

The Cochrane database of systematic reviews 2017; (1()):CD001390 doi:10.1002/14651858.CD001390.pub4.

State-of-the-art testing for alpha-1 antitrypsin deficiency.

Kueppers F, Sanders C

Allergy and asthma proceedings 2017; (38(2)):108-114 doi:10.2500/aap.2017.38.4031.

Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.

Wedzicha JA, Miravitlles M, Hurst JR, et al.

The European respiratory journal 2017; (49(3)) doi:10.1183/13993003.00791-2016.

Alpha-1 Antitrypsin PiMZ Genotype Is Associated with Chronic Obstructive Pulmonary Disease in Two Racial Groups.

Foreman MG, Wilson C, DeMeo DL, et al.

Annals of the American Thoracic Society 2017; (14(8)):1280-1287 doi:10.1513/AnnalsATS.201611-838OC.

Effect of Home Noninvasive Ventilation With Oxygen Therapy vs Oxygen Therapy Alone on Hospital Readmission or Death After an Acute COPD Exacerbation: A Randomized Clinical Trial.

Murphy PB, Rehal S, Arbane G, et al.

JAMA 2017; (317(21)):2177-2186 doi:10.1001/jama.2017.4451.

Improved outcomes in ex-smokers with COPD: a UK primary care observational cohort study.

Josephs L, Culliford D, Johnson M, Thomas M

The European respiratory journal 2017; (49(5)) doi:10.1183/13993003.02114-2016.

American Thoracic Society/National Heart, Lung, and Blood Institute Asthma-Chronic Obstructive Pulmonary Disease Overlap Workshop Report.

Woodruff PG, van den Berge M, Boucher RC, et al.

American journal of respiratory and critical care medicine 2017; (196(3)):375-381 doi:10.1164/rccm.201705-0973WS.

Redefining the overlap of asthma and COPD.

Drug and therapeutics bulletin 2017; (55(7)):66-69 doi:10.1136/dtb.2017.7.0505.

Stage 1 development of a patient-reported experience measure (PREM) for chronic obstructive pulmonary disease (COPD).

Walker S, Andrew S, Hodson M, Roberts CM

NPJ primary care respiratory medicine 2017; (27(1)):47 doi:10.1038/s41533-017-0047-5.

The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult.

Sandhaus RA, Turino G, Brantly ML, et al.

Chronic obstructive pulmonary diseases (Miami, Fla.) 2016; (3(3)):668-682 doi:10.15326/jcopdf.3.3.2015.0182.

A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM).

Kemp SV, Slebos DJ, Kirk A, et al.

American journal of respiratory and critical care medicine 2017; (196(12)):1535-1543 doi:10.1164/rccm.201707-1327OC.

Diagnosis and management of acute exacerbations of chronic obstructive pulmonary disease

Holden V, Slack III D, McCurdy MT, Shah NG

Emergency medicine practice 2017; (19(10)):1-24.

COPD-X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update.

Yang IA, Brown JL, George J, et al.

The Medical journal of Australia 2017; (207(10)):436-442 doi:10.5694/mja17.00686.

Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction.

Gelb AF, Yamamoto A, Verbeken EK, et al.

Chest 2018; (153(3)):618-629 doi:10.1016/j.chest.2017.11.016.

Diagnosing COPD and supporting smoking cessation in general practice: evidence-practice gaps.

Liang J, Abramson MJ, Zwar NA, et al.

The Medical journal of Australia 2018; (208(1)):29-34 doi:10.5694/mja17.00664.

Protocols to Evaluate Cigarette Smoke-Induced Lung Inflammation and Pathology in Mice.

Vlahos R, Bozinovski S

Methods in molecular biology (Clifton, N.J.) 2018; (1725()):53-63 doi:10.1007/978-1-4939-7568-6_5.

Which patients with moderate hypoxemia benefit from long-term oxygen therapy? Ways forward.

Ekström M, Ringbaek T

International journal of chronic obstructive pulmonary disease 2018; (13()):231-235 doi:10.2147/COPD.S148673.

N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study.

Januzzi JL, Chen-Tournoux AA, Christenson RH, et al.

Journal of the American College of Cardiology 2018; (71(11)):1191-1200 doi:10.1016/j.jacc.2018.01.021.

Pulmonary rehabilitation in patients with an acute exacerbation of chronic obstructive pulmonary disease.

Jones SE, Barker RE, Nolan CM, et al.

Journal of thoracic disease 2018; (10(Suppl 12)):S1390-S1399 doi:10.21037/jtd.2018.03.18.

Influenza vaccine for chronic obstructive pulmonary disease (COPD).

Kopsaftis Z, Wood-Baker R, Poole P

The Cochrane database of systematic reviews 2018; (6()):CD002733 doi:10.1002/14651858.CD002733.pub3.

Diagnosis, Prevention and Treatment of Stable COPD and Acute Exacerbations of COPD: The Swiss Recommendations 2018.

Stolz D, Barandun J, Borer H, et al.

Respiration; international review of thoracic diseases 2018; (96(4)):382-398 doi:10.1159/000490551.

What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement.

Kim V, Aaron SD

The European respiratory journal 2018; (52(5)) doi:10.1183/13993003.01261-2018.

Chronic Obstructive Pulmonary Disease in Older Adults: Part II: Considerations for Inhaler Selection.

Bystrak T, Eisenhower C

Journal of gerontological nursing 2018; (44(10)):10-15 doi:10.3928/00989134-20180913-03.

COPD Guidelines: A Review of the 2018 GOLD Report.

Mirza S, Clay RD, Koslow MA, Scanlon PD

Mayo Clinic proceedings 2018; (93(10)):1488-1502 doi:10.1016/j.mayocp.2018.05.026.

Pulmonary Rehabilitation Reduces Emergency Admission and Hospitalization Rates of Patients with Chronic Respiratory Diseases.

Özmen İ, Yıldırım E, Öztürk M, et al.

Turkish thoracic journal 2018; (19(4)):170-175 doi:10.5152/TurkThoracJ.2018.17089.

Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study.

Suissa S, Dell'Aniello S, Ernst P

The Lancet. Respiratory medicine 2018; (6(11)):855-862 doi:10.1016/S2213-2600(18)30368-0.

Under- and over-diagnosis of COPD: a global perspective.

Ho T, Cusack RP, Chaudhary N, et al.

Breathe (Sheffield, England) 2019; (15(1)):24-35 doi:10.1183/20734735.0346-2018.

The Impact of Delayed Diagnosis of Alpha-1 Antitrypsin Deficiency: The Association Between Diagnostic Delay and Worsened Clinical Status.

Tejwani V, Nowacki AS, Fye E, et al.

Respiratory care 2019; (64(8)):915-922 doi:10.4187/respcare.06555.

[The relevance of biomarkers in acute heart failure].

Hellenkamp K, von Haehling S

Der Internist 2019; (60(6)):587-596 doi:10.1007/s00108-019-0606-7.

Bronchodilator reversibility in asthma and COPD: findings from three large population studies.

Janson C, Malinovschi A, Amaral AFS, et al.

The European respiratory journal 2019; (54(3)) doi:10.1183/13993003.00561-2019.

Increased risk of major adverse cardiac events following the onset of acute exacerbations of COPD.

Reilev M, Pottegård A, Lykkegaard J, et al.

Respirology (Carlton, Vic.) 2019; (24(12)):1183-1190 doi:10.1111/resp.13620.

Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial.

Pascoe S, Barnes N, Brusselle G, et al.

The Lancet. Respiratory medicine 2019; (7(9)):745-756 doi:10.1016/S2213-2600(19)30190-0.

Management of asthma COPD overlap.

Maselli DJ, Hanania NA

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2019; (123(4)):335-344 doi:10.1016/j.anai.2019.07.021.

European Respiratory Society guidelines on long-term home non-invasive ventilation for management of COPD.

Ergan B, Oczkowski S, Rochwerg B, et al.

The European respiratory journal 2019; (54(3)) doi:10.1183/13993003.01003-2019.

Prevalence, Contribution to Disease Burden and Management of Comorbid Depression and Anxiety in Chronic Obstructive Pulmonary Disease: A Narrative Review.

Zareifopoulos N, Bellou A, Spiropoulou A, Spiropoulos K

COPD 2019; (16(5-6)):406-417 doi:10.1080/15412555.2019.1679102.

The Ability of Different Scoring Systems to Predict Mortality in Chronic Obstructive Pulmonary Disease Patients: A Prospective Cohort Study.

Kim J, Lee CH, Hwang SS, et al.

Respiration; international review of thoracic diseases 2019; (98(6)):495-502 doi:10.1159/000502826.

Noninvasive positive pressure ventilation in stable patients with COPD.

Wiles SP, Aboussouan LS, Mireles-Cabodevila E

Current opinion in pulmonary medicine 2020; (26(2)):175-185 doi:10.1097/MCP.0000000000000657.

A Systematic Review and Meta-Analysis of Sputum Purulence to Predict Bacterial Infection in COPD Exacerbations.

Chen K, Pleasants KA, Pleasants RA, et al.

COPD 2020; (17(3)):311-317 doi:10.1080/15412555.2020.1766433.

Nonpharmacologic Therapies in Patients With Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review With Meta-Analysis.

Dobler CC, Morrow AS, Farah MH, et al.

Mayo Clinic proceedings 2020; (95(6)):1169-1183 doi:10.1016/j.mayocp.2020.01.018.

Diagnosis of pulmonary embolism in patients with acute exacerbations of chronic obstructive pulmonary disease: A cross-sectional study.

Maritano Furcada J, Castro HM, De Vito EL, et al.

The clinical respiratory journal 2020; (14(12)):1176-1181 doi:10.1111/crj.13257.

Long-Term Noninvasive Ventilation in Chronic Stable Hypercapnic Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline.

Macrea M, Oczkowski S, Rochwerg B, et al.

American journal of respiratory and critical care medicine 2020; (202(4)):e74-e87 doi:10.1164/rccm.202006-2382ST.

Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: Benefits and Risks.

Mkorombindo T, Dransfield MT

Clinics in chest medicine 2020; (41(3)):475-484 doi:10.1016/j.ccm.2020.05.006.

Systematic review and meta-analysis of test accuracy for the diagnosis of suspected pulmonary embolism.

Patel P, Patel P, Bhatt M, et al.

Blood advances 2020; (4(18)):4296-4311 doi:10.1182/bloodadvances.2019001052.

Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline.

Jacobs SS, Krishnan JA, Lederer DJ, et al.

American journal of respiratory and critical care medicine 2020; (202(10)):e121-e141 doi:10.1164/rccm.202009-3608ST.

Correlation of BODE index with quality of life in stable Chronic Obstructive Pulmonary Disease (COPD) patients - A prospective study.

Kamath S, Kumar A, Panda SK, Samanta RP

Journal of family medicine and primary care 2020; (9(11)):5606-5613 doi:10.4103/jfmpc.jfmpc_735_20.

Lung Volume Reduction Surgery Before Lung Transplantation: A Propensity-Matched Analysis.

Krishnan A, Chidi A, Merlo CA, et al.

The Annals of thoracic surgery 2022; (113(2)):491-497 doi:10.1016/j.athoracsur.2021.02.009.

Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact.

MacLeod M, Papi A, Contoli M, et al.

Respirology (Carlton, Vic.) 2021; (26(6)):532-551 doi:10.1111/resp.14041.

Effectiveness of Health Literacy Interventions on COPD Self-Management Outcomes in Outpatient Settings: A Systematic Review.

Shnaigat M, Downie S, Hosseinzadeh H

COPD 2021; (18(3)):367-373 doi:10.1080/15412555.2021.1872061.

GOLD 2021 Strategy Report: Implications for Asthma-COPD Overlap.

Roman-Rodriguez M, Kaplan A

International journal of chronic obstructive pulmonary disease 2021; (16()):1709-1715 doi:10.2147/COPD.S300902.

Emergency admission parameters for predicting in-hospital mortality in patients with acute exacerbations of chronic obstructive pulmonary disease with hypercapnic respiratory failure.

Chen L, Chen L, Zheng H, et al.

BMC pulmonary medicine 2021; (21(1)):258 doi:10.1186/s12890-021-01624-1.

Trends in Incidence, and Mortality of Acute Exacerbation of Chronic Obstructive Pulmonary Disease in the United States Emergency Department (2010-2018).

Nguyen PL, Uddin MM, Mir T, et al.

COPD 2021; (18(5)):567-575 doi:10.1080/15412555.2021.1979500.

Pulmonary Rehabilitation Programmes Within Three Days of Hospitalization for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.

Zhang D, Zhang H, Li X, et al.

International journal of chronic obstructive pulmonary disease 2021; (16()):3525-3538 doi:10.2147/COPD.S338074.

Dysregulated Cell Signaling in Pulmonary Emphysema.

Lin CR, Bahmed K, Kosmider B

Frontiers in medicine 2021; (8()):762878 doi:10.3389/fmed.2021.762878.

Clinical Implications of Bronchodilator Testing: Diagnosing and Differentiating COPD and Asthma-COPD Overlap.

Annangi S, Coz-Yataco AO

Respiratory care 2022; (67(4)):440-447 doi:10.4187/respcare.09215.

Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment.

Yang IA, Jenkins CR, Salvi SS

The Lancet. Respiratory medicine 2022; (10(5)):497-511 doi:10.1016/S2213-2600(21)00506-3.

Isolated Elevation in Lung Residual Volume Is Associated With Airway Diseases.

Kanj AN, Samhouri BF, Poliszuk D, et al.

Respiratory care 2022; (67(7)):842-849 doi:10.4187/respcare.09687.

Evaluation and Management of Asthma and Chronic Obstructive Pulmonary Disease Exacerbation in the Emergency Department.

Long B, Rezaie SR

Emergency medicine clinics of North America 2022; (40(3)):539-563 doi:10.1016/j.emc.2022.05.007.

The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset.

Calverley PMA, Papi A, Page C, et al.

International journal of chronic obstructive pulmonary disease 2022; (17()):1909-1920 doi:10.2147/COPD.S369804.

LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations.

Miravitlles M, Kawayama T, Dreher M

Journal of clinical medicine 2022; (11(22)) doi:10.3390/jcm11226623.

Supplemental oxygen and noninvasive ventilation.

Owens RL, Derom E, Ambrosino N

European respiratory review : an official journal of the European Respiratory Society 2023; (32(167)) doi:10.1183/16000617.0159-2022.

Exacerbation Risk and Mortality in Global Initiative for Chronic Obstructive Lung Disease Group A and B Patients with and without Exacerbation History.

Vanfleteren LEGW, Lindberg A, Zhou C, et al.

American journal of respiratory and critical care medicine 2023; (208(2)):163-175 doi:10.1164/rccm.202209-1774OC.

COPD exacerbations and patient-reported outcomes according to post-bronchodilator FEV1 - a post-hoc analysis of pooled data.

Chai CS, Ng DL, Bt Mos S, et al.

BMC pulmonary medicine 2023; (23(1)):150 doi:10.1186/s12890-023-02436-1.

[COPD - what has changed in GOLD 2023 and is relevant for clinical practice?]

Klemmer A, Alter P, Vogelmeier CF

Deutsche medizinische Wochenschrift (1946) 2023; (148(12)):780-787 doi:10.1055/a-1997-1375.

FEV1/FVC Severity Stages for Chronic Obstructive Pulmonary Disease.

Bhatt SP, Nakhmani A, Fortis S, et al.

American journal of respiratory and critical care medicine 2023; (208(6)):676-684 doi:10.1164/rccm.202303-0450OC.

The role of vaccination in COPD: influenza, SARS-CoV-2, pneumococcus, pertussis, RSV and varicella zoster virus.

Simon S, Joean O, Welte T, Rademacher J

European respiratory review : an official journal of the European Respiratory Society 2023; (32(169)) doi:10.1183/16000617.0034-2023.

Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution.

Parums DV

Medical science monitor : international medical journal of experimental and clinical research 2023; (29()):e942672 doi:10.12659/MSM.942672.

Bronchoscopic lung volume reduction in emphysema: a review.

Ravikumar N, Wagh A, Holden VK, Hogarth DK

Current opinion in pulmonary medicine 2024; (30(1)):58-67 doi:10.1097/MCP.0000000000001031.

Stepwise management of COPD: What is next after bronchodilation?

Miravitlles M, Matsunaga K, Dreher M

Therapeutic advances in respiratory disease 2023; (17()):17534666231208630 doi:10.1177/17534666231208630.

Association Between Sarcopenia and Chronic Renal Failure (Overt and Concealed) in Chronic Obstructive Pulmonary Disease (COPD) Patients: A Cross-Sectional Study.

M Y, Dave AK, Patel SS, et al.

Cureus 2023; (15(10)):e46870 doi:10.7759/cureus.46870.

Overuse of long-acting β2-agonist/inhaled corticosteroids in patients with chronic obstructive pulmonary disease: time to rethink prescribing patterns.

Brunton SA, Hogarth DK

Postgraduate medicine 2023; (135(8)):784-802 doi:10.1080/00325481.2023.2284650.

A Low Eosinophil to Platelet Ratio as a Worse Prognostic Index for Emergency Department Attendance in Acute Exacerbation of COPD.

Hu D, Huang J, Zhao W, et al.

International journal of chronic obstructive pulmonary disease 2024; (19()):139-147 doi:10.2147/COPD.S442715.

Water Sorption and Structural Properties of Human Airway Mucus in Health and Muco-Obstructive Diseases.

Kelly SJ, Genevskiy V, Björklund S, et al.

Biomacromolecules 2024; (25(3)):1578-1591 doi:10.1021/acs.biomac.3c01170.

Inhaled Corticosteroids in Subjects with Chronic Obstructive Pulmonary Disease: An Old, Unfinished History.

Melani AS, Croce S, Fabbri G, et al.

Biomolecules 2024; (14(2)) doi:10.3390/biom14020195.

Respiratory Infection Triggering Severe Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Abi Abdallah G, Diop S, Jamme M, et al.

International journal of chronic obstructive pulmonary disease 2024; (19()):555-565 doi:10.2147/COPD.S447162.

Thoracic Society of Australia and New Zealand clinical practice guideline on adult home oxygen therapy.

McDonald CF, Serginson J, AlShareef S, et al.

Respirology (Carlton, Vic.) 2024; (29(9)):765-784 doi:10.1111/resp.14793.

The effect of recombinant zoster vaccine on patients with chronic obstructive pulmonary diseases: A multi-institutional propensity score-matched cohort study.

Tsai YW, Zhang B, Wu JY, et al.

Journal of medical virology 2024; (96(9)):e29911 doi:10.1002/jmv.29911.

Prediction Model of In-Hospital Death for Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients Admitted to Intensive Care Unit: The PD-ICU Score.

Li X, Yi Q, Luo Y, et al.

Respiration; international review of thoracic diseases 2025; (104(2)):85-99 doi:10.1159/000541367.

Long-acting muscarinic antagonist and long-acting β2-agonist combination for the treatment of maintenance therapy-naïve patients with chronic obstructive pulmonary disease: a narrative review.

Buhl R, Miravitlles M, Anzueto A, Brunton S

Therapeutic advances in respiratory disease 2024; (18()):17534666241279115 doi:10.1177/17534666241279115.

Pulmonary embolism work-up in chronic obstructive pulmonary disease exacerbations: what is the best strategy for clinicians?

Jiménez D, Bertoletti L, Bikdeli B

Current opinion in pulmonary medicine 2025; (31(2)):175-181 doi:10.1097/MCP.0000000000001130.

The effect of a post-bronchodilator FEV1/FVC < 0.7 on COPD diagnosis and treatment: a regression discontinuity design.

Moffett AT, Halpern SD, Weissman GE

Respiratory research 2025; (26(1)):122 doi:10.1186/s12931-025-03198-6.

Vaccination in Chronic Obstructive Pulmonary Disease.

Kwok WC, Wong JC, Cheung A, Tam TC

Vaccines 2025; (13(3)) doi:10.3390/vaccines13030218.

Sputum colour charts to guide antibiotic self-treatment of acute exacerbation of chronic obstructive pulmonary disease: the Colour-COPD RCT.

Gkini E, Adams RL, Spittle D, et al.

Health technology assessment (Winchester, England) 2025; (29(28)):1-42 doi:10.3310/KPFD5558.

Age-adjusted natriuretic peptide thresholds for a diagnosis of heart failure in the community: Diagnostic accuracy study.

Taylor CJ, Taylor KS, Jones NR, et al.

ESC heart failure 2025; (12(5)):3552-3568 doi:10.1002/ehf2.15383.

Surgical lung volume reduction eligibility in an emphysema patient pool referred for endoscopic treatment.

Vandervelde CM, Hartman JE, Klooster K, et al.

BMC pulmonary medicine 2025; (25(1)):479 doi:10.1186/s12890-025-03954-w.

Predictors of Progression in Pre-COPD: The 3P Study Rationale and Design.

González-Villaescusa C, Tarrasó Castillo J, Martínez-Pitarch D, et al.

Open respiratory archives 2026; (8(1)):100519 doi:10.1016/j.opresp.2025.100519.

Plasma growth differentiation factor-15 is associated with cardiovascular events in patients hospitalized for acute exacerbation of COPD.

Sivapalan P, Ackermann DA, Vognsen AK, et al.

Scientific reports 2026; (16(1)):898 doi:10.1038/s41598-025-27988-6.

GOLD 2026: Transforming COPD Management with Early Intervention, Multi-dimensional Assessment, and Personalized Care.

Cazzola M, Bajpai J, Calzetta L, et al.

Drugs 2026; (86(5)):581-597 doi:10.1007/s40265-026-02303-3.

The timing of the commencement of pulmonary rehabilitation in hospitalized patients with acute exacerbation of COPD: a systematic review and network meta-analysis.

Jia P, Zhang H, Li Y, et al.

BMC medicine 2026; (24(1)).

Role of Vaccination in the Prevention of ECOPD.

Sartori F, Crisafulli E, Cariqueo M, et al.

Seminars in respiratory and critical care medicine 2026; (47(3)):323-333 doi:10.1055/a-2837-8778.

Prehospital treatment modalities for acute exacerbation of chronic obstructive pulmonary disease: a scoping review.

Kristensen JT, Bülow A, Jensen ASR, Gude MF

BMC emergency medicine 2026; (26(1)).

[Management of patients with chronic obstructive pulmonary disease in routine clinical practice].

Pott H, Schmeck B, Alter P, Rohde G

Innere Medizin (Heidelberg, Germany) 2026; (67(6)):640-650 doi:10.1007/s00108-026-02111-7.

Alpha-1 Antitrypsin Deficiency-Associated Chronic Obstructive Pulmonary Disease.

Fouka E, Vrouvaki A, Moustaka Christodoulou M, et al.

Medicina (Kaunas, Lithuania) 2026; (62(4)) doi:10.3390/medicina62040639.

Delayed Diagnosis of Alpha-1 Antitrypsin Deficiency in an Elderly Patient.

Ragnoli B, Pochetti P, Veselagu X, Malerba M

Diagnostics (Basel, Switzerland) 2026; (16(9)) doi:10.3390/diagnostics16091329.

Mitochondrial DNA-mediated cGAS-STING activation and its crosstalk with NLRP3 inflammasome in chronic obstructive pulmonary disease.

Jindal D, Chopra V, Garg K, Sharma S

Cytokine & growth factor reviews 2026; (90()):12-25 doi:10.1016/j.cytogfr.2026.05.001.

COPD: A Comprehensive Overview of a Prevalent Disease.

Li ZP

JAAPA : official journal of the American Academy of Physician Assistants 2026; (39(7)):20-27 doi:10.1097/01.JAA.0000000000000377.

GOLD 2026 COPD ABE assessment tool to identify individuals at high risk in a UK multicentre COPD cohort (ERICA).

Adesoye G, Watson A, Zhao T, et al.

BMJ open respiratory research 2026; (13(1)) doi:10.1136/bmjresp-2025-004075.

The relationship between swallowing function and clinical parameters in patients with chronic obstructive pulmonary disease.

Demir Yazici S, Söyler AK, Uçar HA

BMC pulmonary medicine 2026; (26(1)).

The high-risk B-to-E transitional phenotype: a prospective multi-centre validation of patient reclassification under the updated GOLD 2026 criteria.

Zhang B, Zeng J, Zeng H, et al.

Journal of global health 2026; (16()):04205 doi:10.7189/jogh.16.04205.